Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests
Authors
Melen Brinza
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical Institute, Bucharest, Romania
Carol Davila University of Medicine and Pharmacy, Eroii Sanitari Bvd, Bucharest, Romania
Valentina Uscatescu
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical Institute, Bucharest, Romania
Carol Davila University of Medicine and Pharmacy, Eroii Sanitari Bvd, Bucharest, Romania
Mihai Hemcinschi
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical Institute, Bucharest, Romania
Elisabeta Chiriac
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical Institute, Bucharest, Romania
Georgiana Gherghe
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical Institute, Bucharest, Romania
Daniel Coriu
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical Institute, Bucharest, Romania
Carol Davila University of Medicine and Pharmacy, Eroii Sanitari Bvd, Bucharest, Romania
Language: English
Page range: 93 - 100
Submitted on: Nov 1, 2023
Accepted on: Dec 4, 2023
Published on: Jan 29, 2024
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2024 Melen Brinza, Valentina Uscatescu, Mihai Hemcinschi, Elisabeta Chiriac, Georgiana Gherghe, Daniel Coriu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.